Andrew Kruegel was six years into his chemistry work at Columbia University, when, one day in August 2016, he learned he might have only 30 days before the government made him destroy his research.
After psilocybin and ketamine, a new biotech comes along developing a drug Scott Gottlieb fought
July 10, 2020
Articles
12:52 pm
JOIN OUR MAILING LIST
Sign up to receive the latest news on atai.
Email